GENinCode Plc (LON:GENI – Get Free Report) was up 3.7% during trading on Thursday . The company traded as high as GBX 7 ($0.09) and last traded at GBX 7 ($0.09). Approximately 91 shares were traded during mid-day trading, a decline of 100% from the average daily volume of 237,719 shares. The stock had previously closed at GBX 6.75 ($0.09).
GENinCode Stock Performance
The company has a market capitalization of £11.94 million, a PE ratio of -100.00 and a beta of 0.67. The company has a current ratio of 1.28, a quick ratio of 15.89 and a debt-to-equity ratio of 23.20. The business’s fifty day moving average is GBX 6.54 and its two-hundred day moving average is GBX 6.62.
About GENinCode
GENinCode Plc develops and commercializes clinical genetic tests to provide predictive analysis of risk to a patient's health based on their genes in the United Kingdom and internationally. Its predictive technology provides patients and physicians with preventative care and treatment strategies.
Further Reading
- Five stocks we like better than GENinCode
- How Technical Indicators Can Help You Find Oversold Stocks
- Is Merck Stock Undervalued After Its Colossal Earnings Growth?
- What Does a Stock Split Mean?
- Top 5 ETFs for Every Investor: From Semiconductors to Defense
- When to Sell a Stock for Profit or Loss
- Blade Air Mobility: This Under-the-Radar Stock Could Double Soon
Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.
